Den europeiske union - rumensk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxetinei - neuropatii diabetice - psychoanaleptics, - tratamentul durerii neuropatice periferice diabetice la adulți.

Den europeiske union - slovensk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloksetin - diabetične nevropatije - psychoanaleptics, - zdravljenje diabetične periferne nevropatske bolečine pri odraslih.

Den europeiske union - gresk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - ντουλοξετίνη - Διαβητικές νευροπάθειες - psychoanaleptics, - Θεραπεία διαβητικού περιφερικού νευροπαθητικού πόνου σε ενήλικες.

Den europeiske union - fransk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxétine - neuropathies diabétiques - psychoanaleptics, - traitement de la douleur neuropathique périphérique diabétique chez les adultes.

Den europeiske union - spansk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxetina - neuropatías diabéticas - psychoanaleptics, - tratamiento del dolor neuropático periférico diabético en adultos.

Den europeiske union - engelsk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxetine - diabetic neuropathies - psychoanaleptics, - treatment of diabetic peripheral neuropathic pain in adults.

Den europeiske union - italiensk - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - duloxetina - neuropatie diabetiche - psychoanaleptics, - trattamento del dolore neuropatico periferico diabetico negli adulti.

Israel - engelsk - Ministry of Health

boehringer ingelheim israel ltd. - nintedanib as esilate - capsules soft - nintedanib as esilate 100 mg - in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non small cell lung cancer (nsclc) of adenocarcinoma tumor histology after first line chemotherapy.

Israel - engelsk - Ministry of Health

boehringer ingelheim israel ltd. - nintedanib as esilate - capsules soft - nintedanib as esilate 150 mg - in combination with docetaxel for the treatment of adult patients with locally advanced, metastatic or locally recurrent non small cell lung cancer (nsclc) of adenocarcinoma tumor histology after first line chemotherapy.

Israel - engelsk - Ministry of Health

boehringer ingelheim israel ltd. - linagliptin; metformin hydrochloride - film coated tablets - linagliptin 2.5 mg; metformin hydrochloride 1000 mg - metformin - as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both linagliptin and metformin is appropriate. trajenta-duo should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings. trajenta-duo has not been studied in patients with a history of pancreatitis. it is unknown whether patients with a history of pancreatitis are at an increased risk for the development of pancreatitis while using trajenta-duo.